What is the recommended amoxicillin‑clavulanate (Amoxiclav) dosing regimen for a child with acute otitis media?

Amoxicillin-Clavulanate Dosing for Acute Otitis Media in Children

For children with acute otitis media, prescribe high-dose amoxicillin-clavulanate at 90 mg/kg/day of the amoxicillin component with 6.4 mg/kg/day of clavulanate (14:1 ratio formulation), divided into 2 doses daily, for 10 days in children under 2 years or 5 days in older children. 1, 2

When to Use Amoxicillin-Clavulanate vs. Amoxicillin Alone

Use amoxicillin-clavulanate as first-line therapy when:

• The child has received amoxicillin within the previous 30 days 1, 3, 2
• Concurrent purulent conjunctivitis is present (otitis-conjunctivitis syndrome) 1, 3, 4
• The child is under 2 years of age or attends daycare (higher risk of resistant organisms) 2
• Coverage for β-lactamase-producing Moraxella catarrhalis or Haemophilus influenzae is specifically needed 3, 2

Use standard amoxicillin alone (80-90 mg/kg/day) when:

• None of the above criteria are met 3
• The patient has NOT taken amoxicillin in the previous 30 days and does NOT have concurrent purulent conjunctivitis 3

Specific Dosing Calculations

The 14:1 ratio formulation is critical because older formulations with higher clavulanate ratios cause significantly more diarrhea and should be avoided. 4, 2, 5

• Maximum single dose: 2000 mg of amoxicillin 2
• Standard pediatric dose: 90 mg/kg/day amoxicillin with 6.4 mg/kg/day clavulanate, divided twice daily 1, 4, 2, 5
• Example for 19 kg child: Approximately 855 mg amoxicillin with 60.8 mg clavulanate per dose, twice daily 4

Treatment Duration

• Children under 2 years: 8-10 days 3
• Children 2 years and older: 5 days 3
• Standard duration in most guidelines: 10 days 2, 5, 6

Evidence Supporting Twice-Daily Dosing

The FDA-approved twice-daily regimen is as effective as three-times-daily dosing and offers superior adherence. 5 Clinical trials demonstrated comparable efficacy between 875 mg every 12 hours and 500 mg every 8 hours in adults, with significantly less severe diarrhea in the twice-daily group (1% vs 2%). 5 In pediatric AOM trials, the every 12-hour regimen (45/6.4 mg/kg/day) showed comparable cure rates to every 8-hour dosing (40/10 mg/kg/day) at end of therapy (87% vs 82%) and follow-up (67% vs 69%), but with significantly lower diarrhea rates (14% vs 34%). 5, 7, 8

Bacteriologic Efficacy

High-dose amoxicillin-clavulanate achieves excellent bacterial eradication:

• Overall pathogen eradication: 96% 6
• Streptococcus pneumoniae eradication: 98%, including 91% of penicillin-resistant strains (MIC 2-4 mcg/mL) 6
• Haemophilus influenzae eradication: 94% 6
• Superior to azithromycin: 96% vs 80.4% for S. pneumoniae eradication 2

Treatment Failure Management

Clinical improvement should be evident within 48-72 hours. 3, 4, 2

If no improvement or worsening occurs:

• Switch to ceftriaxone 50 mg/kg IM/IV (single dose or 3 consecutive daily doses) 3, 2
• Consider tympanocentesis with culture in children under 2 years to guide antibiotic selection 3

Treatment failure is defined as:

• Worsening condition 3
• Persistence of symptoms beyond 48 hours 3
• Recurrence within 4 days of treatment discontinuation 3

Adverse Effects and Tolerability

The 14:1 ratio formulation minimizes gastrointestinal side effects while maintaining efficacy. 4, 2

Common adverse effects:

• Diarrhea: 14-15% with twice-daily dosing 5
• Diaper dermatitis: 4-6% 5
• Nausea: 3% 5
• Skin rashes/urticaria: 3% 5

Recent evidence suggests even lower clavulanate doses may be effective: A 2017 study found that 80 mg/kg/day amoxicillin with only 2.85 mg/kg/day clavulanate resulted in lower rates of diarrhea (17% vs 26%) and diaper dermatitis (21% vs 33%) compared to standard dosing, with comparable treatment failure rates (12% vs 16%). 9 However, this formulation is not yet FDA-approved or guideline-recommended.

Critical Pitfalls to Avoid

• Do not use amoxicillin-clavulanate formulations with ratios other than 14:1 (such as 7:1 or 4:1), as these cause significantly more diarrhea without improving efficacy. 4, 2
• Ensure the diagnosis is truly acute otitis media with tympanic membrane bulging or new-onset otorrhea, not just isolated redness or otitis media with effusion. 1, 3
• Do not prescribe antibiotics for otitis media with effusion unless it persists beyond 3 months with hearing loss or other complications. 1, 3
• Verify adequate visualization of the tympanic membrane before prescribing; refer to ENT if cerumen prevents proper assessment. 3
• Calculate dosing based on the amoxicillin component, not the total combined weight of both drugs. 4, 2

Real-World Effectiveness

Despite increasing prevalence of β-lactamase-producing bacteria (present in 65.8% of children in one 2024 study), treatment failure with amoxicillin remains uncommon (5.4%) and does not differ significantly between children with and without β-lactamase-producing otopathogens. 10 A 2022 retrospective study of over 1 million children found combined failure and recurrence rates were lowest for amoxicillin (1.7%) compared to amoxicillin-clavulanate (11.3%), cefdinir (10.0%), and azithromycin (9.8%). 11 However, this likely reflects appropriate patient selection, as amoxicillin-clavulanate is reserved for higher-risk cases per guidelines. 1, 3